Healthcare Global Enterprises Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises Limited (HCG, BSE: 539787, NSE: HCG) has submitted its restated Articles of Association to the stock exchanges after shareholders approved them through a postal ballot on August 10, 2025. The amended AOA is intended to give effect to a promoter agreement between the company, the BSA Promoter Group (Dr. B.S. Ajaikumar and family members), and the Purchasers — Hector Asia Holdings II Pte. Ltd. and KIA EBT II Scheme 1. The changes record the inter-se rights and obligations of the Purchasers and the BSA Promoter Group. This follows an earlier intimation on July 11, 2025, which included the Postal Ballot Notice seeking shareholder approval. The disclosure is filed under Regulation 30 of the SEBI LODR Regulations, 2015.
This formalises the governance and ownership rights framework between the existing promoter family and the new institutional Purchasers, potentially affecting board composition, voting dynamics, and future decision-making. Shareholders should review the amended AOA to understand how promoter and investor rights have been codified going forward.